Corporate research in the life sciences endures, despite diminishing in other fields of science.
Results for 'US Food and Drug Administration'
The Open Science movement champions transparency, but how much and how quickly is a matter of dispute.
COMMENT: Life science companies are missing out on the benefits of open innovation.
Even if the biggest cuts since World War II don't eventuate, alternative funding sources must be found.